A detailed history of Great West Life Assurance CO transactions in Replimune Group, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 4,393 shares of REPL stock, worth $47,312. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,393
Previous 4,393 -0.0%
Holding current value
$47,312
Previous $40,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$15.96 - $22.18 $47,385 - $65,852
2,969 Added 208.5%
4,393 $75,000
Q1 2023

May 12, 2023

BUY
$17.48 - $29.09 $6,677 - $11,112
382 Added 36.66%
1,424 $25,000
Q3 2022

Nov 01, 2022

BUY
$15.6 - $21.15 $16,255 - $22,038
1,042 New
1,042 $18,000
Q2 2021

Aug 11, 2021

SELL
$28.5 - $39.37 $19,123 - $26,417
-671 Reduced 39.17%
1,042 $40,000
Q2 2020

Aug 17, 2020

BUY
$9.76 - $25.95 $16,718 - $44,452
1,713 New
1,713 $42,000

Others Institutions Holding REPL

About Replimune Group, Inc.


  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $531M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.